Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis.
Tamura R, Yamanobe Y, Fujioka M, Morimoto Y, Fukumura M, Nakaya M, Oishi Y, Sato M, Ueda R, Fujiwara H, Hikichi T, Noji S, Oishi N, Ozawa H, Ogawa K, Kawakami Y, Ohira T, Yoshida K, Toda M.
Tamura R, et al. Among authors: kawakami y.
J Clin Oncol. 2024 May 22:JCO2302376. doi: 10.1200/JCO.23.02376. Online ahead of print.
J Clin Oncol. 2024.
PMID: 38776485